Monthly Archives: April 2018

Vaccine refusal is contagious

Giving a Vaccine to a Little Boy

Research published today in BMC Public Health, which looked at vaccine-related behaviors in California over a 14 year period, finds that non-medical vaccine exemptions operate in a similar way to a contagious disease with cases emanating from high exemption areas. Here, author for the research, Paul L Delamater, tells us about the findings and what they mean in relation to vaccination policies.

Attention to metabolic energy disturbance is needed to treat relapse of heroin

Heroin_powder

Drug dependence is a major public health crisis. The main goal of treating substance dependence is to prevent relapse. In clinical practice, the risk of relapse remains high even after completion of treatment and prolonged abstinence. Our study published in BMC Neuroscience aims to understand the vulnerability to relapse as it is crucial for the development of an effective treatment for drug addiction.

Advances in Parkinson’s Disease Treatment

Deep Brain Stimulation

In honor of Parkinson’s Awareness Week, we are sharing the new and exciting discoveries in Parkinson’s disease treatment. Drs. Han-Lin Chiang and Yih-Ru Wu, leaders in Parkinson’s disease research, discuss some of the most promising advancements in the treatment of Parkinson’s disease.

3

Systems biology study identifies acquired cancer resistance beyond mutations

cancerblog

Precision targeting offers hope after a life-changing cancer diagnosis. However, some cancers that initially respond to targeted chemotherapy become treatment-resistant — and this may have nothing to do with the drug itself. Hidden layers of regulation that control the activity of genes can produce drug-resistant, surviving cells. New research, published today in BMC Systems Biology helps explain how therapy-resistant cancers arise — findings with important implications for the future of cancer therapy.